| ■ 영문 제목 : Global RNAi Medicine Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02294 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 RNAi 의료의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (siRNA, miRNA, piRNA, 기타)와 용도별 시장규모 (신약 및 개발, 치료, 약물 딜리버리, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 RNAi 의료 시장 점유율 - 지역별 RNAi 의료 시장규모 - 주요지역의 종류별 시장규모 (siRNA, miRNA, piRNA, 기타) - 주요지역의 용도별 시장규모 (신약 및 개발, 치료, 약물 딜리버리, 기타) - 미주의 RNAi 의료 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 RNAi 의료 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 RNAi 의료 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 RNAi 의료 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 RNAi 의료 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Suzhou Ribo Life Science Co.,Ltd., Sirnaomics, GemmaPharma, RiboBio - 조사의 결과/결론 |
According to this latest study, the 2021 growth of RNAi Medicine will have significant change from previous year. By the most conservative estimates of global RNAi Medicine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the RNAi Medicine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of RNAi Medicine market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
siRNA
miRNA
piRNA
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Alnylam Pharmaceuticals
Ionis Pharmaceuticals
Suzhou Ribo Life Science Co.,Ltd.
Sirnaomics
GemmaPharma
RiboBio
1 Scope of the Report 2 Executive Summary 3 RNAi Medicine Market Size by Players 4 RNAi Medicine by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global RNAi Medicine Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. RNAi Medicine Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of siRNA Table 3. Major Players of miRNA Table 4. Major Players of piRNA Table 5. Major Players of Others Table 6. RNAi Medicine Market Size CAGR by Type (2020-2026) & ($ Millions) Table 7. Global RNAi Medicine Market Size by Type (2016-2021) & ($ Millions) Table 8. Global RNAi Medicine Market Size Market Share by Type (2016-2021) Table 9. RNAi Medicine Market Size CAGR by Application (2016-2021) & ($ Millions) Table 10. Global RNAi Medicine Market Size by Application (2016-2021) & ($ Millions) Table 11. Global RNAi Medicine Market Size Market Share by Application (2016-2021) Table 12. Global RNAi Medicine Revenue by Players (2019-2021E) & ($ Millions) Table 13. Global RNAi Medicine Revenue Market Share by Players (2019-2021E) Table 14. RNAi Medicine Key Players Head office and Products Offered Table 15. RNAi Medicine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global RNAi Medicine Market Size by Regions 2016-2021 & ($ Millions) Table 19. Global RNAi Medicine Market Size Market Share by Regions 2016-2021 Table 20. Americas RNAi Medicine Market Size by Country (2016-2021) & ($ Millions) Table 21. Americas RNAi Medicine Market Size Market Share by Country (2016-2021) Table 22. Americas RNAi Medicine Market Size by Type (2016-2021) & ($ Millions) Table 23. Americas RNAi Medicine Market Size Market Share by Type (2016-2021) Table 24. Americas RNAi Medicine Market Size by Application (2016-2021) & ($ Millions) Table 25. Americas RNAi Medicine Market Size Market Share by Application (2016-2021) Table 26. APAC RNAi Medicine Market Size by Region (2016-2021) & ($ Millions) Table 27. APAC RNAi Medicine Market Size Market Share by Region (2016-2021) Table 28. APAC RNAi Medicine Market Size by Type (2016-2021) & ($ Millions) Table 29. APAC RNAi Medicine Market Size Market Share by Type (2016-2021) Table 30. APAC RNAi Medicine Market Size by Application (2016-2021) & ($ Millions) Table 31. APAC RNAi Medicine Market Size Market Share by Application (2016-2021) Table 32. Europe RNAi Medicine Market Size by Country (2016-2021) & ($ Millions) Table 33. Europe RNAi Medicine Market Size Market Share by Country (2016-2021) Table 34. Europe RNAi Medicine Market Size by Type (2016-2021) & ($ Millions) Table 35. Europe RNAi Medicine Market Size Market Share by Type (2016-2021) Table 36. Europe RNAi Medicine Market Size by Application (2016-2021) & ($ Millions) Table 37. Europe RNAi Medicine Market Size Market Share by Application (2016-2021) Table 38. Middle East & Africa RNAi Medicine Market Size by Region (2016-2021) & ($ Millions) Table 39. Middle East & Africa RNAi Medicine Market Size Market Share by Region (2016-2021) Table 40. Middle East & Africa RNAi Medicine Market Size by Type (2016-2021) & ($ Millions) Table 41. Middle East & Africa RNAi Medicine Market Size Market Share by Type (2016-2021) Table 42. Middle East & Africa RNAi Medicine Market Size by Application (2016-2021) & ($ Millions) Table 43. Middle East & Africa RNAi Medicine Market Size Market Share by Application (2016-2021) Table 44. Key and Potential Regions of RNAi Medicine Table 45. Key Application and Potential Industries of RNAi Medicine Table 46. Key Challenges of RNAi Medicine Table 47. Key Trends of RNAi Medicine Table 48. Global RNAi Medicine Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 49. Global RNAi Medicine Market Size Market Share Forecast by Regions (2021-2026) Table 50. Global RNAi Medicine Market Size Forecast by Type (2021-2026) & ($ Millions) Table 51. Global RNAi Medicine Market Size Market Share Forecast by Type (2021-2026) Table 52. Global RNAi Medicine Market Size Forecast by Application (2021-2026) & ($ Millions) Table 53. Global RNAi Medicine Market Size Market Share Forecast by Application (2021-2026) Table 54. Alnylam Pharmaceuticals Details, Company Type, RNAi Medicine Area Served and Its Competitors Table 55. Alnylam Pharmaceuticals RNAi Medicine Product Offered Table 56. Alnylam Pharmaceuticals RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 57. Alnylam Pharmaceuticals Main Business Table 58. Alnylam Pharmaceuticals Latest Developments Table 59. Ionis Pharmaceuticals Details, Company Type, RNAi Medicine Area Served and Its Competitors Table 60. Ionis Pharmaceuticals RNAi Medicine Product Offered Table 61. Ionis Pharmaceuticals Main Business Table 62. Ionis Pharmaceuticals RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 63. Ionis Pharmaceuticals Latest Developments Table 64. Suzhou Ribo Life Science Co.,Ltd. Details, Company Type, RNAi Medicine Area Served and Its Competitors Table 65. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Product Offered Table 66. Suzhou Ribo Life Science Co.,Ltd. Main Business Table 67. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 68. Suzhou Ribo Life Science Co.,Ltd. Latest Developments Table 69. Sirnaomics Details, Company Type, RNAi Medicine Area Served and Its Competitors Table 70. Sirnaomics RNAi Medicine Product Offered Table 71. Sirnaomics Main Business Table 72. Sirnaomics RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 73. Sirnaomics Latest Developments Table 74. GemmaPharma Details, Company Type, RNAi Medicine Area Served and Its Competitors Table 75. GemmaPharma RNAi Medicine Product Offered Table 76. GemmaPharma Main Business Table 77. GemmaPharma RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 78. GemmaPharma Latest Developments Table 79. RiboBio Details, Company Type, RNAi Medicine Area Served and Its Competitors Table 80. RiboBio RNAi Medicine Product Offered Table 81. RiboBio Main Business Table 82. RiboBio RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 83. RiboBio Latest Developments List of Figures Figure 1. RNAi Medicine Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global RNAi Medicine Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global RNAi Medicine Market Size Market Share by Type in 2020 Figure 7. RNAi Medicine in Drug Discovery & Development Figure 8. Global RNAi Medicine Market: Drug Discovery & Development (2016-2021) & ($ Millions) Figure 9. RNAi Medicine in Therapeutics Figure 10. Global RNAi Medicine Market: Therapeutics (2016-2021) & ($ Millions) Figure 11. RNAi Medicine in Drug Delivery Figure 12. Global RNAi Medicine Market: Drug Delivery (2016-2021) & ($ Millions) Figure 13. RNAi Medicine in Others Figure 14. Global RNAi Medicine Market: Others (2016-2021) & ($ Millions) Figure 15. Global RNAi Medicine Market Size Market Share by Application in 2020 Figure 16. Global RNAi Medicine Revenue Market Share by Player in 2020 Figure 17. Global RNAi Medicine Market Size Market Share by Regions (2016-2021) Figure 18. Americas RNAi Medicine Market Size 2016-2021 ($ Millions) Figure 19. APAC RNAi Medicine Market Size 2016-2021 ($ Millions) Figure 20. Europe RNAi Medicine Market Size 2016-2021 ($ Millions) Figure 21. Middle East & Africa RNAi Medicine Market Size 2016-2021 ($ Millions) Figure 22. Americas RNAi Medicine Market Size Market Share by Country in 2020 Figure 23. Americas RNAi Medicine Market Size Market Share by Type in 2020 Figure 24. Americas RNAi Medicine Market Size Market Share by Application in 2020 Figure 25. United States RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 26. Canada RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 27. Mexico RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 28. APAC RNAi Medicine Market Size Market Share by Regions in 2020 Figure 29. APAC RNAi Medicine Market Size Market Share by Type in 2020 Figure 30. APAC RNAi Medicine Market Size Market Share by Application in 2020 Figure 31. China RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 32. Japan RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 33. Korea RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 34. Southeast Asia RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 35. India RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 36. Australia RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 37. Europe RNAi Medicine Market Size Market Share by Country in 2020 Figure 38. Europe RNAi Medicine Market Size Market Share by Type in 2020 Figure 39. Europe RNAi Medicine Market Size Market Share by Application in 2020 Figure 40. Germany RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 41. France RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 42. UK RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 43. Italy RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 44. Russia RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 45. Middle East & Africa RNAi Medicine Market Size Market Share by Region in 2020 Figure 46. Middle East & Africa RNAi Medicine Market Size Market Share by Type in 2020 Figure 47. Middle East & Africa RNAi Medicine Market Size Market Share by Application in 2020 Figure 48. Egypt RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 49. South Africa RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 50. Israel RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 51. Turkey RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 52. GCC Country RNAi Medicine Market Size Growth 2016-2021 ($ Millions) Figure 53. Americas RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 54. APAC RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 55. Europe RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 56. Middle East & Africa RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 57. United States RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 58. Canada RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 59. Mexico RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 60. Brazil RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 61. China RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 62. Japan RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 63. Korea RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 64. Southeast Asia RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 65. India RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 66. Australia RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 67. Germany RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 68. France RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 69. UK RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 70. Italy RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 71. Russia RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 72. Spain RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 73. Egypt RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 74. South Africa RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 75. Israel RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 76. Turkey RNAi Medicine Market Size 2021-2026 ($ Millions) Figure 77. GCC Country RNAi Medicine Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 RNAi 의료 시장예측 2021년-2026년] (코드 : LPI-2201K02294) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 RNAi 의료 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |